Evidence-informed decisions for better health
Canada's Drug Agency (CDA-AMC) (cadth.ca) scores 79 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Government brands, in the 64th percentile of 10159 Healthcare brands.
Canada's Drug Agency (CDA-AMC) is a pan-Canadian health organization headquartered in Ottawa, founded in 1989 and funded by federal, provincial, and territorial governments. It operates as an independent government health agency that provides evidence-based information and recommendations on drugs and health technologies to support informed decision-making by health system leaders across Canada.
| Brand Name | Canada's Drug Agency (CDA-AMC) |
|---|---|
| Domain | cadth.ca |
| Industry | Healthcare, Government |
| Founded | 1989 |
| Headquarters | Ottawa |
| Main Competitors | National Institute for Health and Care Excellence (NICE) (91/100), Institute for Clinical and Economic Review (ICER), Institute for Quality and Efficiency in Health Care (IQWiG) (56/100), Haute Autorité de Santé (HAS) (76/100), Pharmaceutical Benefits Advisory Committee (PBAC) (69/100) |
Moz Domain Authority 57/100 vs category average 41 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #348,586 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Canada’s Drug Agency is a pan-Canadian health organization, created and funded by Canada’s federal, provincial, and territorial governments." (No meta description. OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description, og:image, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, Drupal.
Social footprint: verified profiles on Facebook, LinkedIn, YouTube, Instagram, X (Twitter); no detected presence on GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Canada's Drug Agency (CDA-AMC)?", Claude could identify the brand as of September 2026. Canada's Drug Agency (CDA-AMC) is the rebranded successor to CADTH, a Canadian organization that provides evidence-based assessments on drugs, medical devices, and health technologies to help guide decisions by Canada's healthcare systems. It conducts health technology assessment Best known for Conducting health technology assessments and drug reimbursement reviews for Canada's public healthcare systems.
When asked "Best brands similar to Canada's Drug Agency (CDA-AMC)?", Claude would recommend Canada's Drug Agency (CDA-AMC) as of September 2026. If someone asked about health technology assessment or drug policy bodies in Canada, this would be the primary organization to mention given its central role in evaluating drugs and devices for public funding decisions.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Canada's Drug Agency (CDA-AMC)'s main competitors in Healthcare: National Institute for Health and Care Excellence (NICE) (91/100), Institute for Quality and Efficiency in Health Care (IQWiG) (56/100), Haute Autorité de Santé (HAS) (76/100), Pharmaceutical Benefits Advisory Committee (PBAC) (69/100).
Sources: Brand Analyzer scan
Canada's Drug Agency (CDA-AMC) is a pan-Canadian, independent government health organization created and funded by Canada's federal, provincial, and territorial governments. Headquartered in Ottawa and founded in 1989, it provides evidence-based assessments and recommendations on drugs and health technologies to inform health system decision-making across the country.
Canada's Drug Agency (CDA-AMC) has limited AI-search visibility, scoring 38/100 on Brand Analyzer's AI visibility composite (visibility 28, trust 29, recommendation 66). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Canada's Drug Agency (CDA-AMC) was founded in 1989. Canada's Drug Agency (CDA-AMC) operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Canada's Drug Agency (CDA-AMC) is headquartered in Ottawa. Canada's Drug Agency (CDA-AMC) operates in the Healthcare category.
Sources: Wikidata
Canada's Drug Agency (CDA-AMC) scores 66/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
CDA-AMC offers evidence-based assessments and recommendations on drugs and health technologies, providing independent analysis intended to guide decision-making by health system leaders, policy makers, and healthcare providers across Canada's federal, provincial, and territorial health systems.
Canada's Drug Agency (CDA-AMC) can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
CDA-AMC is used by government health officials, hospital administrators, healthcare providers, policy makers, and other health system leaders across Canada's federal, provincial, and territorial governments who rely on its evidence-based assessments to make informed drug and health technology decisions.
CDA-AMC is known for being Canada's trusted, independent authority on health technology assessment and drug policy guidance, delivering unbiased, evidence-based evaluations of drugs and health technologies used by governments and health system leaders across the country.
Canada's Drug Agency (CDA-AMC) scores 38/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Canada's Drug Agency (CDA-AMC) has a weak AI-visibility profile at 38/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (66/100) and its weakest is visibility (28/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #348,586 (Tranco) and a Moz Domain Authority of 57/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Canada's Drug Agency (CDA-AMC) from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Canada's Drug Agency (CDA-AMC): Byram Healthcare (79/100), Cromwell Hospital (79/100), Cake Maternity (79/100), Cambian (79/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.